92 reports

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney Disease - Drugs In Development, 2021, provides an overview of the End-Stage Kidney Disease (Genito...

  • Renal Disease
  • World
  • Drug Approval

Polycystic Kidney Disease (Genitourinary Disorders) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease - Drugs In Development, 2021, provides an overview of the Polycystic Kidney Disease (Genetic Disorders) pipeline landscape. Polycystic...

  • Renal Disease
  • Drug Development
  • World
  • Drug Approval
  • In Patient Average Length Of Stay

Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021 Summary clinical trial report, “Polycystic Kidney Disease - Global Clinical Trials Review, H1, 2021" provides an overview of Polycystic Kidney Disease Clinical trials scenario. This report provides top line data relating to the clinical...

  • Renal Disease
  • Clinical Trial
  • World
  • Stem Cell Transplantation

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney Disease - Pipeline Review, H2 2020, provides an overview of the End-Stage Kidney Disease (Genito Urinary System And Sex Hormones)...

  • Renal Disease
  • World
  • Stem Cell Transplantation

Polycystic Kidney Disease - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease - Pipeline Review, H2 2020, provides an overview of the Polycystic Kidney Disease (Genetic Disorders) pipeline landscape. Polycystic...

  • Renal Disease
  • World
  • Drug Approval
  • Hospital Occupancy Rate

The global kidney disease market is expected to reach US$ 133,444.71 million by 2027 from US$ 81,128.11 million in 2019. The market is estimated to grow at a CAGR of 6.5% from 2020 to 2027. High prevalence of chronic diseases leading to kidney diseases, and favorable reimbursement policy for the kidney disease treatments are the major...

  • Renal Disease
  • APAC
  • World
  • Chronic Disease Prevalence
  • Health Expenditure

Market Introduction Kidney disease means that the kidneys are damaged and cannot filter blood as they should.This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis,...

  • Renal Disease
  • Middle East
  • Africa
  • Diabetes Prevalence
  • Overweight Prevalence

The Europe kidney disease market is expected to reach US$ 37,311.1 million by 2027 from US$ 23,121.5 million in 2019. The market is estimated to grow with a CAGR of 6.2% from 2020 to 2027. Factors such as increasing incidences of chronic kidney diseases and increase in government expenditure in the healthcare sector are expected to fuel...

  • Renal Disease
  • Europe
  • Health Expenditure
  • Mortality Rate

The Asia Pacific kidney disease market is expected to reach US$ 37,204.4 million by 2027 from US$ 21,930.1 million in 2019. The market is estimated to grow with a CAGR of 6.9% from 2020 to 2027. Factors such as increasing incidences of end-stage diseases and high development in government expenditure in the healthcare industry are expected...

  • Renal Disease
  • APAC
  • Patients Undergoing Dialysis
  • Health Expenditure

Market Introduction Kidney disease is also known as renal disease.It is caused due to the malfunctioning of the kidney. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others. For the treatment and diagnosis of these types of diseases, different global and regional...

  • Renal Disease
  • North America
  • Drug Approval
  • Final Consumption Expenditures

The South & Central America kidney disease market is expected to reach US$ 9,060.9 million by 2027 from US$ 5,758.9 million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020 to 2027. The growth of this market is estimated attributed to the factors such as higher prevalence of kidney diseases in South & Central America...

  • Renal Disease
  • Central America
  • Brazil
  • Argentina
  • Patients Undergoing Dialysis
  • Health Expenditure

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney Disease – Pipeline Review, H1 2020, provides an overview of the End-Stage Kidney Disease (Genito Urinary System And Sex...

  • Renal Disease
  • World
  • Stem Cell Transplantation
  • Drug Approval

Renal Disease Treatment Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Renal Disease Treatment Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Renal Disease Treatment Devices types,...

  • Renal Disease
  • World

Polycystic Kidney Disease - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Kidney Disease - Pipeline Review, H1 2020, provides an overview of the Polycystic Kidney Disease (Genetic Disorders) pipeline landscape. Polycystic...

  • Renal Disease
  • World
  • Drug Approval
  • Life Insurance Claims

Abstract: - Global End-Stage Renal Disease Market to Reach $155.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for End-Stage Renal Disease estimated at US$74.4 Billion in the year 2020, is projected to reach a revised size of US$155.4 Billion by 2027, growing at a CAGR of 11.1% over the analysis period...

  • Renal Disease
  • World
  • China
  • United States

The Global Blood Purification Equipment Market size is expected to reach $19.2 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period. Blood purification refers to a method that includes blood withdrawal from the body of a patient into a machine or a device to eliminate impurities and send it back into the body....

  • Renal Disease
  • Blood Disease
  • Hospital
  • APAC
  • Europe
  • North America
  • Mortality Rate

Global Polycystic Kidney Disease Drugs Market 2021-2025 The analyst has been monitoring the polycystic kidney disease drugs market and it is poised to grow by $ 485.71 mn during 2021-2025 progressing at a CAGR of 7% during the forecast period. Our report on polycystic kidney disease drugs market provides a holistic analysis,...

  • Renal Disease
  • World

Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 Summary Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 provides an overview of the Kidney Disease (Nephropathy) pipeline landscape. The report...

  • Renal Disease
  • World

Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc. and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to grow from $12.45 billion in 2021 to $13.94 billion in 2022 at a compound annual growth rate (CAGR) of 11.9%. The growth...

  • Biopharmaceutical
  • Chronic Disease
  • Renal Disease
  • World
  • Europe
  • United States
  • Middle East
  • APAC
  • Brazil

Nephrology Drugs Market by Drug Class (ACE Inhibitors, Calcium Channel Blocker, Beta Blockers, Diuretics, Erythropoiesis-stimulating Agent, and Others), Route of Administration (Oral, Parenteral, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry...

  • Urology
  • Renal Disease
  • Pharmacy
  • World
  • APAC
  • Overweight Prevalence

The global prevalence of CKD is estimated to be about 9% to 10%.Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and...

  • Chronic Disease
  • Renal Disease
  • Managed Care
  • Antidiabetics
  • Heart Failure
  • Hypertension
  • World

Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd. The global erythropoietin (EPO) market is expected to grow from $0.96 billion in 2020 to $1.1 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The growth is...

  • Chronic Disease
  • Biopharmaceutical
  • Pharmaceutical
  • Renal Disease
  • World
  • Europe
  • Germany
  • United States
  • APAC
  • Brazil

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H1, 2020 Summary clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H1, 2020" provides an overview of End-Stage Kidney Disease (End-Stage Renal...

  • Clinical Trial
  • Renal Disease
  • World

Blood Purification Equipment Market by Product Type(Portable and Stationary), Indication (Sepsis, Renal Diseases, and Others) and End User (Hospitals and Clinics, Dialysis Centers and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027 Blood purification allows removal of toxic or pathogenic substances...

  • Chronic Disease
  • Renal Disease
  • Diabetes
  • World
  • APAC
  • Diabetes Incidence

This report is 80% complete and can be delivered within three working days post order confirmation and will include the latest impact analysis of Covid-19 in 2020 and forecast. Global Creatinine Assay Market By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease, Others), By Method (O’Leary modified Jaffe assay,...

  • Renal Disease
  • World
  • Meat Consumption

The global hemodialysis market reached a value of US$ 80 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 4.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...

  • Chronic Disease
  • Dialysis Device
  • Research And Development
  • Hemodialysis Device
  • Hypertension
  • Renal Disease
  • Health Services
  • Genitourinary System Disease
  • World

Tryptophan 2,3 Dioxygenase - Pipeline Review, H1 2020 Summary According to the recently published report ’Tryptophan 2,3 Dioxygenase - Pipeline Review, H1 2020’; Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC...

  • Oncology
  • Pharmaceutical
  • Renal Disease
  • Research Center
  • World
  • Netherlands

Apheresis Equipment Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Apheresis Equipment market including the COVID-19 pandemic implications...

  • Blood Supply
  • Renal Disease
  • Infectious Disease
  • APAC
  • Central America

The Global Urinary Drainage Bags Market size is expected to reach $2.3 billion by 2026, rising at a market growth of 5.7% CAGR during the forecast period. Urine drainage bags collect urine and are mostly used in hospitals. This bag is designed in such a way that it is attached to a catheter (tube) or sheath that is put inside the urinary bladder...

  • Genitourinary System Disease
  • Catheter
  • Renal Disease
  • Dementia
  • Bladder Cancer
  • Marketing Research
  • Urology
  • Incontinence Product
  • Chronic Disease
  • Urology Device
  • World

2020 End Stage Kidney Disease (ESRD) PIPELINE HIGHLIGHTS End Stage Kidney Disease (ESRD) is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of End Stage Kidney Disease (ESRD) medicines is identified as integral to the strategy of the...

  • Renal Disease
  • World
  • Number Of Enterprises